Literature DB >> 33442016

Immune determinants of COVID-19 disease presentation and severity.

Petter Brodin1,2.   

Abstract

COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.

Entities:  

Mesh:

Year:  2021        PMID: 33442016     DOI: 10.1038/s41591-020-01202-8

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  69 in total

1.  Why is COVID-19 so mild in children?

Authors:  Petter Brodin
Journal:  Acta Paediatr       Date:  2020-04-15       Impact factor: 2.299

2.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

3.  The implications of silent transmission for the control of COVID-19 outbreaks.

Authors:  Seyed M Moghadas; Meagan C Fitzpatrick; Pratha Sah; Abhishek Pandey; Affan Shoukat; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.

Authors:  Joan C Smith; Erin L Sausville; Vishruth Girish; Monet Lou Yuan; Anand Vasudevan; Kristen M John; Jason M Sheltzer
Journal:  Dev Cell       Date:  2020-05-16       Impact factor: 12.270

6.  COVID-19: immunopathology and its implications for therapy.

Authors:  Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2020-05       Impact factor: 53.106

7.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

8.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

9.  Viral dynamics in mild and severe cases of COVID-19.

Authors:  Yang Liu; Li-Meng Yan; Lagen Wan; Tian-Xin Xiang; Aiping Le; Jia-Ming Liu; Malik Peiris; Leo L M Poon; Wei Zhang
Journal:  Lancet Infect Dis       Date:  2020-03-19       Impact factor: 25.071

10.  Sex differences in immune responses that underlie COVID-19 disease outcomes.

Authors:  Takehiro Takahashi; Mallory K Ellingson; Patrick Wong; Benjamin Israelow; Carolina Lucas; Jon Klein; Julio Silva; Tianyang Mao; Ji Eun Oh; Maria Tokuyama; Peiwen Lu; Arvind Venkataraman; Annsea Park; Feimei Liu; Amit Meir; Jonathan Sun; Eric Y Wang; Arnau Casanovas-Massana; Anne L Wyllie; Chantal B F Vogels; Rebecca Earnest; Sarah Lapidus; Isabel M Ott; Adam J Moore; Albert Shaw; John B Fournier; Camila D Odio; Shelli Farhadian; Charles Dela Cruz; Nathan D Grubaugh; Wade L Schulz; Aaron M Ring; Albert I Ko; Saad B Omer; Akiko Iwasaki
Journal:  Nature       Date:  2020-08-26       Impact factor: 49.962

View more
  163 in total

1.  Potential Association between the Use of Anabolic Steroids and COVID-19 Infection.

Authors:  Yusuf S Althobaiti; Mohammed S Alzahrani; Shahad M Alhumayani; Shaima A Assiry; Hadeel F Aljuaid; Majed A Algarni
Journal:  Healthcare (Basel)       Date:  2022-01-20

Review 2.  The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.

Authors:  Davies Adeloye; Omer Elneima; Luke Daines; Krisnah Poinasamy; Jennifer K Quint; Samantha Walker; Chris E Brightling; Salman Siddiqui; John R Hurst; James D Chalmers; Paul E Pfeffer; Petr Novotny; Thomas M Drake; Liam G Heaney; Igor Rudan; Aziz Sheikh; Anthony De Soyza
Journal:  Lancet Respir Med       Date:  2021-08-17       Impact factor: 30.700

3.  Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.

Authors:  Adrian Gervais; Tom Le Voyer; Jérémie Rosain; Quentin Philippot; Jérémy Manry; Eleftherios Michailidis; Hans-Heinrich Hoffmann; Shohei Eto; Marina Garcia-Prat; Lucy Bizien; Alba Parra-Martínez; Rui Yang; Liis Haljasmägi; Mélanie Migaud; Karita Särekannu; Julia Maslovskaja; Evangelos Vandreakos; Olivier Hermine; Aurora Pujol; Pärt Peterson; Trine H Mogensen; Lee Rowen; James Mond; Xavier de Lamballerie; Xavier Duval; France Mentré; Marie Zins; Pere Soler-Palacin; Roger Colobran; Guy Gorochov; Xavier Solanich; Sophie Susen; Javier Martinez-Picado; Didier Raoult; Marc Vasse; Peter K Gregersen; Lorenzo Piemonti; Carlos Rodríguez-Gallego; Luigi D Notarangelo; Helen C Su; Kai Kisand; Satoshi Okada; Anne Puel; Emmanuelle Jouanguy; Charles M Rice; Pierre Tiberghien; Qian Zhang; Aurélie Cobat; Laurent Abel; Jean-Laurent Casanova; Paul Bastard; Nicolas de Prost; Yacine Tandjaoui-Lambiotte; Charles-Edouard Luyt; Blanca Amador-Borrero; Alexandre Gaudet; Julien Poissy; Pascal Morel; Pascale Richard; Fabrice Cognasse; Jesus Troya; Sophie Trouillet-Assant; Alexandre Belot; Kahina Saker; Pierre Garçon; Jacques G Rivière; Jean-Christophe Lagier; Stéphanie Gentile; Lindsey B Rosen; Elana Shaw; Tomohiro Morio; Junko Tanaka; David Dalmau; Pierre-Louis Tharaux; Damien Sene; Alain Stepanian; Bruno Megarbane; Vasiliki Triantafyllia; Arnaud Fekkar; James R Heath; José Luis Franco; Juan-Manuel Anaya; Jordi Solé-Violán; Luisa Imberti; Andrea Biondi; Paolo Bonfanti; Riccardo Castagnoli; Ottavia M Delmonte; Yu Zhang; Andrew L Snow; Steven M Holland; Catherine Biggs; Marcela Moncada-Vélez; Andrés Augusto Arias; Lazaro Lorenzo; Soraya Boucherit; Boubacar Coulibaly; Dany Anglicheau; Anna M Planas; Filomeen Haerynck; Sotirija Duvlis; Robert L Nussbaum; Tayfun Ozcelik; Sevgi Keles; Ahmed A Bousfiha; Jalila El Bakkouri; Carolina Ramirez-Santana; Stéphane Paul; Qiang Pan-Hammarström; Lennart Hammarström; Annabelle Dupont; Alina Kurolap; Christine N Metz; Alessandro Aiuti; Giorgio Casari; Vito Lampasona; Fabio Ciceri; Lucila A Barreiros; Elena Dominguez-Garrido; Mateus Vidigal; Mayana Zatz; Diederik van de Beek; Sabina Sahanic; Ivan Tancevski; Yurii Stepanovskyy; Oksana Boyarchuk; Yoko Nukui; Miyuki Tsumura; Loreto Vidaur; Stuart G Tangye; Sonia Burrel; Darragh Duffy; Lluis Quintana-Murci; Adam Klocperk; Nelli Y Kann; Anna Shcherbina; Yu-Lung Lau; Daniel Leung; Matthieu Coulongeat; Julien Marlet; Rutger Koning; Luis Felipe Reyes; Angélique Chauvineau-Grenier; Fabienne Venet; Guillaume Monneret; Michel C Nussenzweig; Romain Arrestier; Idris Boudhabhay; Hagit Baris-Feldman; David Hagin; Joost Wauters; Isabelle Meyts; Adam H Dyer; Sean P Kennelly; Nollaig M Bourke; Rabih Halwani; Narjes Saheb Sharif-Askari; Karim Dorgham; Jérome Sallette; Souad Mehlal Sedkaoui; Suzan AlKhater; Raúl Rigo-Bonnin; Francisco Morandeira; Lucie Roussel; Donald C Vinh; Sisse Rye Ostrowski; Antonio Condino-Neto; Carolina Prando; Anastasiia Bonradenko; András N Spaan; Laurent Gilardin; Jacques Fellay; Stanislas Lyonnet; Kaya Bilguvar; Richard P Lifton; Shrikant Mane; Mark S Anderson; Bertrand Boisson; Vivien Béziat; Shen-Ying Zhang; Stéphanie Debette
Journal:  Sci Immunol       Date:  2021-08-19

4.  Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Authors:  Tobias Moll; Valerie Odon; Calum Harvey; Mark O Collins; Andrew Peden; John Franklin; Emily Graves; Jack Ng Marshall; Cleide Dos Santos Souza; Sai Zhang; Lydia Castelli; Guillaume Hautbergue; Mimoun Azzouz; David Gordon; Nevan Krogan; Laura Ferraiuolo; Michael P Snyder; Pamela J Shaw; Jan Rehwinkel; Johnathan Cooper-Knock
Journal:  Life Sci Alliance       Date:  2022-10-14

5.  Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.

Authors:  Manuela Funke-Chambour; Pierre-Olivier Bridevaux; Christian F Clarenbach; Paola M Soccal; Laurent P Nicod; Christophe von Garnier
Journal:  Respiration       Date:  2021-06-04       Impact factor: 3.580

6.  Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.

Authors:  Rafaela Pires da Silva; João Ismael Budelon Gonçalves; Rafael Fernandes Zanin; Felipe Barreto Schuch; Ana Paula Duarte de Souza
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

7.  Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.

Authors:  Martine Policard; Sidharth Jain; Samantha Rego; Sivanesan Dakshanamurthy
Journal:  Virus Res       Date:  2021-05-28       Impact factor: 3.303

Review 8.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07

9.  Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.

Authors:  Emiko Desvaux; Antoine Hamon; Sandra Hubert; Cheïma Boudjeniba; Bastien Chassagnol; Jack Swindle; Audrey Aussy; Laurence Laigle; Jessica Laplume; Perrine Soret; Pierre Jean-François; Isabelle Dupin-Roger; Mickaël Guedj; Philippe Moingeon
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

Review 10.  Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.

Authors:  Yasuo Okada; Ken Yoshimura; Shuji Toya; Makoto Tsuchimochi
Journal:  Jpn Dent Sci Rev       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.